Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Science Communication
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by RESNIK, D.
Right arrow Search for Related Content
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Data Falsification in Clinical Trials

DAVID RESNIK

University of Wyoming

This article uses an infamous case of data falsification in clinical research as a starting point for a deeper analysis of some of the motivations and obligations that could encourage misconduct in a clinical setting. The article argues that the use of alternative, less rigid experimental designs and protocols could help lessen the pressures on researchers to falsify clinical data pertaining to patient records, and that it is worth considering alternative designs to benefit patients and help promote integrity in medical research.

Science Communication, Vol. 18, No. 1, 49-58 (1996)
DOI: 10.1177/1075547096018001003


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?